Diastolic dysfunction in pressure-overload hypertrophy and its modification by angiotensin II: current concepts
Author:
- 1 January 1992
- book chapter
- Published by Springer Nature
- p. 163-172
Abstract
Cardiac hypertrophy is an adaptive response to an increased load imposed on the myocyte which allows the heart to perform increased work while maintaining normal myocardial fiber stress and shortening in systole. A deleterious consequence of pressure-overload hypertrophy is the prolongation of Ca2+-sensitive force inactivation (impaired myocardial relaxation) which is related to intrinsic alterations in cytosolic Ca2+ transport and reuptake in diastole. Additional factors appear to adversely modify myocardial relaxation in the hypertrophied heart, including the imposition of ischemia. There is also evidence that the expression and activity of the cardiac tissue renin angiotensin system (RAS) may be modified in the hypertrophied heart and contribute to diastolic dysfunction. Recent studies have demonstrated the presence of increased cardiac angiotensin converting enzyme (ACE) mRNA expression and activity in animal models of hypertrophy, including the aortic-banded rat with compensatory pressure-overload hypertrophy and rats with post-infarction remodeling. In the beating, isovolumic aortic-banded rat heart, the increased intracardiac activation of angiotensin I to II has been shown to be associated with a dose-dependent depression of diastolic relaxation. Preliminary studies suggest that the depression of diastolic function by angiotensin II in the hypertrophied heart can be prevented by the specific inhibition of cardiac ACE. In addition, the well-recognized susceptibility of the hypertrophied heart to severe ischemic diastolic dysfunction also appears to be favorably modified by the inhibition of cardiac ACE activity. The mechanisms responsible for the adverse effects of angiotensin II on diastolic relaxation in the hypertrophied heart are likely to be complex. These factors may include the modification of coronary vasomotor tone as well as effects on intracellular Ca2+ handling mediated by phosphoinositide second messengers. Further studies are needed to clarify the myocardial effects of angiotensin II activation on diastolic relaxation. Much work will also need to be done to determine if intrinsic activity of the cardiac RAS is modified in patients with advanced hypertrophy, and if cardiac angiotensin II activation contributes to diastolic dysfunctiion and heart failure.Keywords
This publication has 33 references indexed in Scilit:
- Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy.Circulation, 1990
- Postischemic recovery of mechanical performance and energy metabolism in the presence of left ventricular hypertrophy. A 31P-MRS study.Circulation Research, 1990
- Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat.Circulation Research, 1990
- Characterization of avian angiotensin II cardiac receptors: Coupling to mechanical activity and phosphoinositide metabolismJournal of Molecular and Cellular Cardiology, 1989
- Identification and characterization of guinea pig angiotensin II ventricular and atrial receptors: coupling to inositol phosphate production.Circulation Research, 1988
- Cardiac renin-angiotensin systemThe American Journal of Medicine, 1988
- Phorbol ester increases calcium current and simulates the effects of angiotensin II on cultured neonatal rat heart myocytes.Circulation Research, 1988
- Altered left ventricular diastolic properties during pacing-induced angina in patients with aortic stenosis.Circulation, 1986
- Altered calcium handling in experimental pressure-overload hypertrophy in the ferret.Circulation Research, 1985
- Identification and characterization of the rabbit angiotensin II myocardial receptor.Circulation Research, 1984